The present study showed a statistically significant association between the change in the CD4/CD8 ratio before and after one course of immunotherapy and the downward tendency of the CD4/CD8 ratio during one course of immunotherapy, suggesting an active immunological response against cancer invasion. This evidence concerns the gene CD4 and cancer.